Induction of cytotoxic T lymphocytes to murine mammary tumor cells with a Kd-restricted immunogenic peptide

International Journal of Cancer

Volumn 66, Issue 5, 1996, Pages 659-663

  Wei, Wei Zen ^a,b   Gill, Randall F ^a,b   Jones, Richard F ^a,b   Lichlyter, Darcy ^a,b   Abastado, Jean Pierre ^c  

^a KARMANOS CANCER INSTITUTE   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FREUND ADJUVANT; TUMOR ANTIGEN; TUMOR ANTIGEN E 474; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; ARTICLE; BREAST TUMOR; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; FEMALE; FLOW CYTOMETRY; IMMUNIZATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG NODULE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, NEOPLASM; CELL DIVISION; HISTOCOMPATIBILITY ANTIGENS CLASS I; LYMPHOCYTE ACTIVATION; MAMMARY NEOPLASMS, EXPERIMENTAL; MAMMARY TUMOR VIRUS, MOUSE; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; OLIGOPEPTIDES; PEPTIDE BIOSYNTHESIS; PEPTIDES; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED; VIRAL ENVELOPE PROTEINS;

EID: 0030008644     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0215(19960529)66:5<659::aid-ijc13>3.0.co;2-#     Document Type: Article

References (19)

1. ABASTADO, J.P., OJCIUS, D., YEH, P., SCHUMACHER, T., PLOEGH, H. and KOURILSKY, P., A soluble, single-chain Kd molecule produced by yeast selects a peptide repertoire indistinguishable from that of cell-surface-associated Kd. Europ. J. Immunol. 23, 1776-1783 (1993).
2. FALK, K., ROTZSCHKE, O., STEVANOVIC, S., JUNG, G. and RAMMENSEE. H.G., Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature (Lond.), 351, 290-296 (1991).
3. FASEL, N., BUETTI, E., FIRZLAFF, J., PEARSON, K. and DIGGELMANN, H., Nucleotide sequence of the 5′ noncoding region and part of the gag gene of mouse mammary tumor virus; identification of the 5′ splicing site for subgenomic mRNAs. Nucleic Acids Res., 11, 6943-6955 (1983).
4. GAUGLER, B., VAN DEN EYNDE, B., VAN DER BRUGGEN, P., ROMERO, P., GAFORIO, J.J., DE PLAEN, E., LETHE, B., BRASSEUR, F. and BOON, T., Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J. exp. Med., 179, 921-930 (1994).
5. GILL, R.F., ABASTADO, J.P. and WEI, W.Z., Systematic identification of H-2Kd binding peptides and induction of peptide specific CTL. J. Immunol. Meth., 176, 245-253 (1994).
6. JOANNIDES, C.G., FISK, B., FAN, D., BIDDISON, W.A., WHARTON, J.T. and O'BRIAN, C.A., Cytotoxic T cells isolated from ovarian malignant ascites recognize a peptide derived from the Her-2/neu protooncogene. Cell. Immunol., 151, 225-234 (1993).
7. JEROME, K.R., BARND, D.L., BENDT, K.M., BOYER, C.M., TAYLOR-PAPADIMITRIOU, J., MCKENZIE, I F.C., BAST, R.C. and FINN, O.J., Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells. Cancer Res., 51, 2908-2916 (1991).
8. KOZAK, C. and 20 OTHERS. A standard nomenclature for endogenous mouse mammary tumor viruses. J. Virol., 61, 1651-1654 (1987).
9. - cytotoxic T lymphocyte that mediate specific tumor rejection. J. Immunol, 151, 6283-6290 (1993).
10. MAHONEY, K.H., MILLER, B.E. and HEPPNER, G.H., FACS quantitation of leucine aminopeptidase and acid phosphatase on tumor associated macrophages from metastatic and nonmetastatic mouse mammary tumors. J. Leukocyte Biol., 38, 573-585 (1985).
11. MAJORS, J.E. and VARMUS, H.E., Nucleotide sequencing of an apparent proviral copy of env mRNA defines determinants of expression of the mouse mammary virus env gene. J. Virol., 47, 495-504 (1983).
12. MEDINA, D. and ASCH, B.B., Cell markers for mouse mammary preneoplasia. In: C.M. McGrath, M.J. Brennan and M.A.C. Rich (eds.). Cell biology of breast cancer, pp. 363-371, Academic Press, London (1980).
13. PAULEY, R.J. and LOPEZ, D.M., Expression of endogenous Mtv provirus transcripts in BALB/c splenic lymphocytes. Proc. Soc. exp. Biol. Med., 196, 316-320 (1991).
14. RINGOLD, G.M., BLAIR, P.B., BISHOP, J.M. and VARMUS, H.E., Nucleotide sequence homologies among mouse mammary tumor viruses. Virology, 70, 550-553 (1976).
15. SEITE, A. and 16 OTHERS. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J. Immunol., 153, 5586-5592 (1994).
16. SHAKHOV, A.N., WANG, H., ACHA-ORBEA, H., PAULEY, R.J. and WEI, W.Z., A new infectious mammary tumor virus in the milk of mice implanted with C4 hyperplastic alveolar nodules. Europ. J. Immunol., 23, 2765-2769 (1993).
17. + T cells and thymocytes by apoptosis in mouse mammary tumor virus (C4) infected Vβ2 transgenic mice. Europ. J. Immunol. 24, 2950-2956 (1994).
18. WEI, W.-Z., GILL, R.F. and WANG, H., Mouse mammary tumor virus associated antigens and superantigens - immuno - molecular correlates of neoplastic progression. Sem. Cancer Biol., 4, 205-213 (1993).
19. YOSHINO, I., GOEDGEBURRE, P.S., PEOPLES, G.E., PARIKH, A.S., DIMAIO, J.M., LYERLY, H.K., GAIDAR, A.F. and EBERLEIN, T.J., HER-2/neu-derived peptides are shared antigens among human non-small cell lung cancer and ovarian cancer. Cancer Res., 54, 3387-3390 (1994).